Trupanion Q2 2026 earnings: Subscription growth lifts operating profit

Trupanion (NASDAQ: TRUP) reported Q2 2026 revenue of $392.9 million, up 11% from $353.6 million a year earlier, while diluted EPS fell to $0.16 from $0.22. Subscription growth, improved claims economics, and stronger cash generation lifted operating income and adjusted EBITDA, but lower non-operating income reduced GAAP net income.

Core earnings data

Revenue grew faster than cost of revenue, lifting calculated gross profit by about 19% and expanding gross margin by roughly 1.1 percentage points. Operating expenses increased about 12%, led by higher technology and development and new pet acquisition spending, but the gross-profit increase was sufficient to raise operating income to $6.4 million.

The divergence between higher operating profit and lower net income is important: adjusted EBITDA and cash flow improved, while GAAP earnings were affected by a less favorable year-over-year comparison in non-operating income.

Gross profit and related margins are calculated as revenue less cost of revenue. Adjusted EBITDA and free cash flow are non-GAAP measures.

Business and segment performance

The subscription business remained Trupanion’s primary growth driver. Subscription revenue rose faster than enrolled subscription pets, supported by a 9.4% increase in monthly average revenue per pet and slightly higher retention.

The enrollment picture was mixed, however. Subscription pets increased 5%, while total enrolled pets declined 2%, indicating that weakness outside the subscription segment continued to offset part of the core business’s expansion.

Within the subscription segment, the non-GAAP cost of paying veterinary invoices declined to 70.2% of revenue from 71.1%. Variable expenses edged down to 9.0% from 9.1%, while allocated fixed expenses fell to 5.8% from 6.0%. These changes supported the 1.2-point expansion in subscription adjusted operating margin.

Operating improvement was offset by lower non-operating income

Trupanion’s operating income increased from $2.3 million to $6.4 million, but net income declined from $9.4 million to $6.8 million. The difference came mainly from non-operating items rather than deterioration in the underlying business.

Net other income fell to $2.8 million from $11.9 million. The prior-year quarter included a $7.8 million realized gain from the nonmonetary exchange of a preferred stock investment. Although interest expense declined to $1.8 million from $3.7 million, that benefit did not offset the reduction in other income. As a result, pretax income fell to $7.4 million from $10.5 million despite the higher operating profit.

Cash flow and balance sheet

Cash conversion improved during the quarter. Operating cash flow reached $21.0 million, and $1.8 million of capital expenditures resulted in free cash flow of $19.2 million.

At June 30, 2026, Trupanion held $398.5 million in cash and short-term investments, compared with approximately $370.7 million at the end of 2025. Current and long-term debt totaled $106.9 million, down from $111.8 million at year-end, and the company reported another $3.5 million available under its credit facility.

In July, the New York Department of Financial Services approved a $44 million extraordinary dividend from American Pet Insurance Company to its parent, Trupanion. This is an intercompany payment rather than a dividend to public shareholders. Separately, the board authorized up to $100 million of share repurchases with no expiration date. The authorization does not require any purchases, and the timing will depend on available cash, operating cash flow, credit-facility compliance, market conditions, and alternative uses of capital.

Management perspective

CEO and President Margi Tooth emphasized margin growth, improving the economics of new enrollments, and disciplined capital allocation. Average pet acquisition cost fell sequentially to $299 from $315 in Q1 2026, although it remained above the $276 reported a year earlier. The margin improvement and stronger free cash flow provide measurable support for the company’s focus on operating efficiency and capital discipline.

Recent insider transactions

The provided six-month holder data categorized 134,172 shares across 31 transactions as purchases and 39,310 shares across 13 transactions as sales. That produced reported net purchases of 94,862 shares, equal to 1.4% of the 6.87 million total insider shares held.

Seven of the latest ten provided records disclosed both a transaction action and value. Three direct records dated May 22, 2026 lacked those details and are excluded below.

These records describe the transactions but do not, by themselves, establish insiders’ views of Trupanion’s outlook.

Risks investors should monitor

• Enrollment remains uneven. Subscription enrollment increased, but total enrolled pets declined 2%. Continued contraction outside the subscription business could limit consolidated volume growth.
• Acquisition costs increased year over year. Average pet acquisition cost rose to $299 from $276, while subscription acquisition cost increased to 7.8% of subscription revenue from 7.5%. Further increases could reduce the returns from new-member growth.
• Claims economics remain central to margins. The subscription veterinary-invoice cost ratio improved this quarter, but higher claim severity or frequency—and delays in implementing pricing changes—could reverse that progress.
• Technology spending is rising. Technology and development expense increased to $12.8 million from $8.6 million. These investments could constrain operating leverage if they continue growing faster than revenue without producing corresponding benefits.
• Repurchases could affect liquidity. The $100 million authorization is optional, but actual repurchases would compete with debt reduction, growth investment, and other uses of cash.

Summary

Trupanion’s Q2 2026 results showed improving underlying operations: subscription revenue and revenue per pet grew, claims costs consumed a smaller share of subscription revenue, and both operating profit and free cash flow increased. GAAP net income declined because the prior-year quarter benefited from a sizable investment-related gain. Investors’ next focus should be whether Trupanion can sustain margin expansion while addressing declining total enrollment and controlling acquisition and technology spending.

Find out more